Intel Capital and Tengelmann Ventures are set to exit data processing technology developer Data Artisans, having backed its $6.3m series A round.

Minnesota-founded microbial analysis spinout CoreBiome has been bought by medical diagnostics firm OraSure Technology after raising $1.4m from investors including Minnesota’s Discovery Capital fund.

Eli Lilly-backed biotech companies HJB and MabSpace have agreed to merge into a newly formed business called Transcenta.

Bristol-Myers Squibb is set to buy peer Celgene in a cash-and-stock deal that will bring together two healthcare corporate venturing portfolios.

Boston Scientific has exercised its option to wholly acquire Millipede, based on research at Michigan, having purchased a $90m stake in the mitral regurgitation treatment device maker last year.

Boston Scientific has exercised its option to wholly acquire Millipede, having purchased a $90m stake in the mitral regurgitation treatment device maker last year.

Cisco and Ingram Micro are among the investors in virtualisation software producer Parallels, which has been acquired by Corel for an undisclosed sum.

Tokyo Electron is set to exit optical transceiver producer Luxtera after Cisco has confirmed it intends to pay $660m to buy the company.

GV has exited POC-focused health and beauty product manufacturer Walker and Company in an acquisition of undisclosed size by Procter & Gamble.

ICL vascular implant spinout Veryan Medical has been bought by medical device firm Otsuka after raising $56m from investors including IP Group.